CureVac BV Q3 2022 Earnings Preview
- CureVac BV (NASDAQ:CVAC) is scheduled to announce Q3 earnings results on Wednesday, November 16th, before market open.
- The consensus EPS Estimate is -$0.24 and the consensus Revenue Estimate is $19.77M
- Over the last 3 months, EPS estimates have seen 1 upward revision and 1 downward. Revenue estimates have seen 1 upward revision and 1 downward.